
Robert Sebra, PhD
About Me
Robert Sebra, PhD, is a Professor in the Department of Genetics and Genomic Sciences, Director of The Center for Advanced Genomics Technology, and Director of Technology Development for the Genomics Core Facility at the Icahn School of Medicine at Mount Sinai. He is a faculty member of the Icahn Genomics Institute. His research lab centers on creating and applying bulk and single cell molecular methods to generate highly resolved data using genomics technology for variant discovery and annotation. This research integrates single molecular and cellular genomics data with assays to assess chromatin accessibility, proteomics, and epigenetics data to decipher factors of pathogenesis versus normal cellular functions. Determining which cellular niches and mechanisms in complex primary tissues drive disease or resilience facilitates translation of functional genomics data using model systems for screening possible downstream regenerative and therapeutic potential using high throughput methods.
Ongoing research interests include:
- Developing novel molecular methods and genome sequencing technologies
- Advancing high-throughput functional genomics
- Exploring whole genome and repeat content characterization for disease association
- Analyzing surveillance and genomic characterization of pathogen transmission
- Using genomics to temporally characterize development and pathogenesis
- Translating genomic data in various oncologic diseases including gynecologic and breast cancers
Language
English
Position
PROFESSOR | Genetics and Genomic Sciences
Research Topics
Biomedical Informatics, Cancer, Cancer Genetics, Epigenetics, Gene Expressions, Genetics, Infectious Disease, Molecular Biology, RNA, RNA Splicing & Processing, Stem Cells, Technology & Innovation, Translational Research
Multi-Disciplinary Training Areas
Genetics and Genomic Sciences [GGS]
Publications
Selected Publications
- Tracking HIV persistence across T cell lineages during early ART-treated HIV-1-infection using a reservoir-marking humanized mouse model. Namita Satija, Foramben Patel, Gerrit Schmidt, Donald V. Doanman, Manav Kapoor, Annalena La Porte, Ying Chih Wang, Kenneth M. Law, Anthony M. Esposito, Kimaada Allette, Kristin G. Beaumont, Robert P. Sebra, Benjamin K. Chen. Nature Communications
- TNFR1-mediated senescence and lack of TNFR2-signaling limit human intervertebral disc cell repair potential in degenerative conditions. Jennifer Gansau, Elena Grossi, Levon Rodriguez, Minghui Wang, Damien M. Laudier, Saad Chaudhary, Andrew C. Hecht, Wenyu Fu, Robert Sebra, Chuan Ju Liu, James C. Iatridis. Osteoarthritis and Cartilage
- Atezolizumab plus personalized neoantigen vaccination in urothelial cancer: a phase 1 trial. Mansi Saxena, Jonathan F. Anker, Julia Kodysh, Timothy O’Donnell, Anna M. Kaminska, Marcia Meseck, Olivia Hapanowicz, Scot Anthony Niglio, Andres M. Salazar, Hardik R. Shah, Yayoi Kinoshita, Rachel Brody, Alex Rubinsteyn, Robert P. Sebra, Nina Bhardwaj, Matthew D. Galsky. Nature Cancer